21 drug companies with new highs in the year reported results, with 76.19% of the company's shares

"Pharmaceutical Network Industry Dynamics" July 15, the pharmaceutical sector rose against the market, a total of 64 pharmaceutical stocks hit a new high (excluding the second new shares listed during the year), of which 5 stocks, including Guanyu Bio, all closed at the price of the rise and fallAccording to incomplete statistics in the industry, as of July 15, a total of 129 pharmaceutical companies disclosed the results of the report or the report, of which the performance of the company reached 63, accounting for 48.84 percentOf the 64 pharmaceutical companies with new highs in share prices during the year, 21 disclosed their earnings forecasts, of which 16, or 76.19 per cent, reported positive results16 companies with pre-news prices hit new highs this year, including Zhejiang Pharmaceuticals, Yingke Medical, Crown Bio, Wanfu Bio, XinheCheng, Changchun High-tech, Tianyu Shares, Shanda Huat, Jianfan Bio, Meirui Medical, Lizhu Group, Puli Pharmaceuticals, Hepri and othersAmong them, Crown Bio rose 10.01 percent to close at 29.99 yuanThe company is engaged in regenerative medical materials and regenerative biological medical implant device research and development, production and sales of high-tech enterprisesCrown Bio recently disclosed the results of the mid-report forecast shows that the first half of 2020 is expected to make a profit of 25 million yuan - 27 million yuan, an increase of 190%-210% year-on-yearDuring the reporting period, the company's sales department market input decreased, sales expenses decreased, the company's management actively reduced the efficiency, the reporting period of the management expenses decreased significantly, the cost of the decline to a certain extent affected the company's net profitInmedicine, a leading domestic manufacturer of disposable medical supplies and medical durable equipment, rose 4.74 percent to close at 175.55 yuanRecently, Yingke Medical in Shenzhen Stock Exchange issued an unaudited half-year results forecast, said that as of June 30, 2020, the company's net profit of 1.9 billion yuan - 2.1 billion yuan, the same period last year' profit of 70.84 million yuan, an increase of 2581.8 percent -2864.1 percent year-on-yearThe company explained the main reasons for the change in performanceGlobal demand for disposable protective gloves surged, and the company's price of disposable protective gloves increased significantly, resulting in an increase in the company's sales revenue and gross margin in the first half of the yearIn addition, Wanfu Bio and Xinhecheng reported a relatively large change in net profit, the increase of more than 100%Wanfu Bio is mainly engaged in rapid diagnostic reagents, rapid detection instruments and other POCT-related products research and development, production and salesIn the first half of this year, Wanfu Bio's net profit attributable to shareholders of listed companies was 413 million yuan-453 million yuan, an increase of 100%-120% over the same period last year, according to the company's July 6 earnings forecast for its 2020 mid-year resultsThe reasons for the change in performance are closely related to the surge in demand for testing reagentsIt is worth mentioning that Wanfu Bio not only has strong growth, but also the share price is climbing Since January this year, Wanfu Bio's share price has risen from 30 yuan per share, breaking through the 100 yuan/share mark, and the stock price has risen nearly 300% so far this year New and Cheng's first-half profit was RMB2,196 million to RMB2,311 million, up 90%-100% YoY, mainly due to an increase in sales prices and sales of products such as vitamin A, vitamin E, biotin and other products during the reporting period compared with the same period last year At the same time as the results climbed, Xinhe's share price rose 24.47 percent during the year, with a market value of more than 60 billion yuan Data show that Xinhecheng is a mainly engaged in raw materials, nutrition, fragrance scents and polymer composite new materials production and sales of high-tech enterprises